Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Sep 22, 2009

Premium

Charles Lee and David Barker have been selected to serve on the advisory team of BioNanomatrix.

Lee is director of cytogenetics for the Harvard Cancer Center and an associate professor of pathology at Harvard Medical School.

Barker formerly was chief scientific officer at Illumina, and he was VP and chief science adviser at Amersham Biosciences, and VP of research and business development at Molecular Dynamics.


Kreatech CEO Lex Altink is stepping down from his position with the company and will be replaced by Kees Moonen at an upcoming shareholder meeting.

Altink said in a statement that he is leaving the company because "I consider my mission completed." However, he noted that he will stay on the firm's board as an advisor.


Navigenics has appointed Michael Critelli to its board of directors. Critelli spent nearly three decades at Pitney Bowes, where he was CEO for 11 years and chairman for 12. He currently is chairman of the board for the Dossia Foundation.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.